2004). These final results show that ginsenoside Rg3 guards neurons in vitro from NMDA-induced neurotoxicity As well as in vivo ginsenoside Rh2 safeguards from ischemia-reperfusion brain injuries. The neuroprotective activity of such ginsenosides may be attributed to the particular inhibition of NMDA-induced receptor activation.Raltegravir has been